E. Gomez

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert et al. · European Respiratory Journal · 2023 · 121 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2017 update. Full-length version

Vincent Cottin, B. Crestani, J. Cadranel et al. · Revue des Maladies Respiratoires · 2017 · 64 citations

Medicine, Clinical Sciences, Internal Medicine +14

Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: Evidence for a dysregulation at central level

Mathias Poussel, Catherine Thil, P. Kaminsky et al. · Neuromuscular Disorders · 2015 · 60 citations

Life Sciences, Physiology, Pathophysiology +16

Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease

Louis Chauvelot, D. Gamondès, Julien Berthiller et al. · Arthritis & Rheumatology · 2020 · 57 citations

Medicine, Clinical Sciences, Internal Medicine +13

Rituximab for auto-immune alveolar proteinosis, a real life cohort study

B. Soyez, Raphaël Borie, Cédric Menard et al. · Respiratory Research · 2018 · 52 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9